skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Biomarkers in bone disease Preview this item
ClosePreview this item
Checking...

Biomarkers in bone disease

Author: Victor R Preedy
Publisher: Dordrecht : Springer, 2016.
Series: Springer reference live.; Biomarkers in disease.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Publication:Springer Nature Living Reference
Summary:
In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage,  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Victor R Preedy
ISBN: 9789400777453 9400777450
OCLC Number: 1110884689
Notes: "Living reference work."
Description: 1 online resource : illustrations
Contents: Serum uric acid and biomarkers of lumbar spine bone mineral density --
Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget's disease of the bone --
Bone Turnover and Spinal Cord Injury --
Bone-related proteins as markers in vascular remodelling --
Serum Sclerostin as Biomarker in Osteogenesis Imperfecta --
Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology --
Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption --
Use of bone biomarkers after weight loss: Example of bariatric surgery --
Adiponectin as biomarker of osteoporosis --
Effect of statins on bone turnover markers --
Chitinases as biomarkers in bone studies --
Hormone relaxin as biomarker for bone health and disease --
Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis --
Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML) --
Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers --
Traditional medicine and use of bone biomarkers --
Osteosarcoma Biomarkers discovery using "omics" approaches --
Creatine kinase as biomarker in osteogenesis imperfecta --
Ameloblastin as biomarker of bone --
Biomarker genes in autosomal dominant osteopetrosis type II (ADO II) --
Bone markers in Rett syndrome --
Bone Specific Alkaline Phosphatase and Exercise --
Bone turnover markers and glucocorticoid treatments --
Overview of biochemical markers of bone metabolism --
Biomarkers of natural radionuclides in bone and teeth --
Bone markers throughout sexual development: epidemiological significance and population-based findings --
Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity --
Quantitative ultrasound as a biomarker tool in newborn infants for bone --
Bone biomarkers in gestational hypertension --
Bone biomarkers in intrauterine growth restriction --
Raman spectroscopy as a biomarker-investigative tool in bone metabolism --
Pentosidine as a biomarker for poor bone quality and elevated fracture risk --
Spine bone texture and the trabecular bone score (TBS) --
Bone biomarkers in HIV --
Bone Biomarkers Related to Osteoarthritis --
Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis --
Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide --
Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis --
Circulating Sclerostin in Bone Sclerosing Disorders --
Pentraxin 3 as a bone biomarker --
Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis --
Tartarate resistant acid phosphatase as a biomarker of bone remodeling.
Series Title: Springer reference live.; Biomarkers in disease.
Responsibility: edited by Victor R. Preedy.

Abstract:

In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1110884689<\/a>> # Biomarkers in bone disease<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:MediaObject<\/a>, schema:CreativeWork<\/a>, schema:Book<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1110884689<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/ne<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/oncology<\/a>> ; # Oncology<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/toxicology<\/a>> ; # Toxicology<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/bones_diseases_diagnosis<\/a>> ; # Bones--Diseases--Diagnosis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/dewey.info\/class\/616.71075\/e23\/<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/biochemical_markers<\/a>> ; # Biochemical markers<\/span>\n\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> schema:EBook<\/a> ;\u00A0\u00A0\u00A0\nschema:contributor<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Person\/preedy_victor_r<\/a>> ; # Victor R. Preedy<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2016<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"Serum uric acid and biomarkers of lumbar spine bone mineral density -- Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget\'s disease of the bone -- Bone Turnover and Spinal Cord Injury -- Bone-related proteins as markers in vascular remodelling -- Serum Sclerostin as Biomarker in Osteogenesis Imperfecta -- Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology -- Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption -- Use of bone biomarkers after weight loss: Example of bariatric surgery -- Adiponectin as biomarker of osteoporosis -- Effect of statins on bone turnover markers -- Chitinases as biomarkers in bone studies -- Hormone relaxin as biomarker for bone health and disease -- Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis -- Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML) -- Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers -- Traditional medicine and use of bone biomarkers -- Osteosarcoma Biomarkers discovery using \"omics\" approaches -- Creatine kinase as biomarker in osteogenesis imperfecta -- Ameloblastin as biomarker of bone -- Biomarker genes in autosomal dominant osteopetrosis type II (ADO II) -- Bone markers in Rett syndrome -- Bone Specific Alkaline Phosphatase and Exercise -- Bone turnover markers and glucocorticoid treatments -- Overview of biochemical markers of bone metabolism -- Biomarkers of natural radionuclides in bone and teeth -- Bone markers throughout sexual development: epidemiological significance and population-based findings -- Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity -- Quantitative ultrasound as a biomarker tool in newborn infants for bone -- Bone biomarkers in gestational hypertension -- Bone biomarkers in intrauterine growth restriction -- Raman spectroscopy as a biomarker-investigative tool in bone metabolism -- Pentosidine as a biomarker for poor bone quality and elevated fracture risk -- Spine bone texture and the trabecular bone score (TBS) -- Bone biomarkers in HIV -- Bone Biomarkers Related to Osteoarthritis -- Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis -- Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide -- Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis -- Circulating Sclerostin in Bone Sclerosing Disorders -- Pentraxin 3 as a bone biomarker -- Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis -- Tartarate resistant acid phosphatase as a biomarker of bone remodeling.<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:editor<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Person\/preedy_victor_r<\/a>> ; # Victor R. Preedy<\/span>\n\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/4389372057<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Electronic books<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Series\/springer_reference_live<\/a>> ; # Springer reference live.<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/worldcat.org\/issn\/2542-3665<\/a>> ; # Biomarkers in Disease: Methods, Discoveries and Applications,<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Series\/biomarkers_in_disease<\/a>> ; # Biomarkers in disease.<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biomarkers in bone disease<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1110884689<\/span>\" ;\u00A0\u00A0\u00A0\nschema:url<\/a> <https:\/\/doi.org\/10.1007\/978-94-007-7745-3<\/a>> ;\u00A0\u00A0\u00A0\nschema:workExample<\/a> <http:\/\/worldcat.org\/isbn\/9789400777453<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1110884689<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/dewey.info\/class\/616.71075\/e23\/<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Person\/preedy_victor_r<\/a>> # Victor R. Preedy<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Preedy<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Victor R.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Victor R. Preedy<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Series\/biomarkers_in_disease<\/a>> # Biomarkers in disease.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1110884689<\/a>> ; # Biomarkers in bone disease<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biomarkers in disease.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Series\/springer_reference_live<\/a>> # Springer reference live.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1110884689<\/a>> ; # Biomarkers in bone disease<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Springer reference live.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Springer reference live<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/biochemical_markers<\/a>> # Biochemical markers<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biochemical markers<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/bones_diseases_diagnosis<\/a>> # Bones--Diseases--Diagnosis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Bones--Diseases--Diagnosis<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/oncology<\/a>> # Oncology<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Oncology<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4389372057#Topic\/toxicology<\/a>> # Toxicology<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Toxicology<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/ne<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"ne<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/isbn\/9789400777453<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:ProductModel<\/a> ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"9400777450<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"9789400777453<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/issn\/2542-3665<\/a>> # Biomarkers in Disease: Methods, Discoveries and Applications,<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1110884689<\/a>> ; # Biomarkers in bone disease<\/span>\n\u00A0\u00A0\u00A0\nschema:issn<\/a> \"2542-3665<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biomarkers in Disease: Methods, Discoveries and Applications,<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n